Intended for healthcare professionals


Covid-19: six million doses of hydroxychloroquine donated to US despite lack of evidence

BMJ 2020; 368 doi: (Published 23 March 2020) Cite this as: BMJ 2020;368:m1166

Read our latest coverage of the coronavirus outbreak

  1. Elisabeth Mahase
  1. The BMJ

Drug company Teva has said that it will donate more than six million doses of hydroxychloroquine sulfate tablets to hospitals across the US, to “meet the urgent demand for the medicine as an investigational target to treat covid-19.”

The company said that the drug—which is currently used to treat malaria and rheumatoid arthritis—had been requested by “US government officials to be made available for use immediately.”

Discussing the drug at a televised press conference, president Donald Trump said that it had shown “very, very encouraging early results” and incorrectly suggested that the Food and Drug Administration (FDA) had already approved it for the treatment of covid-19. The FDA has since made clear that this is not the case and that there are “no FDA-approved therapeutics or drugs to …

View Full Text